Neural Therapeutics Inc. stock analysis
Neural Therapeutics Inc. (NURL) Stock Price & Analysis
NURL Stock Chart & Stats
- Day’s Range
- CAD 0.01 - CAD 0.01
- 52-Week Range
- CAD 0.01 - CAD 0.04
- Previous Close
- CAD 0.01
- Volume
- N/A
- Average Volume (3M)
- 48.30K
- Market Cap
- CAD 843.50K
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- -0.19
- Next Earnings
- Nov 20, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Neural Therapeutics Inc. News
Neural Therapeutics Revises CWE Financing, Resets Shareholder Meeting and Grants RSUs
The latest announcement is out from Neural Therapeutics Inc. ( ($TSE:NURL) ). Neural Therapeutics Inc. has amended its strategic investment and option agreement with CWE European Holdings Inc., shifting the
Neural Therapeutics’ Hanf.com Stake Delivers 58% Revenue Surge and Positive Operating Income
The latest update is out from Neural Therapeutics Inc. ( ($TSE:NURL) ). Neural Therapeutics Inc. reported that its portfolio company CWE European Holdings, operating as Hanf.com, achieved approximately 58% year‑over‑year
Neural’s Hanf.com Begins German Sales of Ritual Herbs Tobacco-Free Smoking Blends
Neural Therapeutics Inc. ( ($TSE:NURL) ) has provided an announcement. Neural Therapeutics’ portfolio company CWE European Holdings, operating as Hanf.com, has begun sales of Ritual Herbs’ nicotine- and tobacco-free herbal
Neural Therapeutics’ Portfolio Company Hanf.com Reports Strong Financial Growth
Neural Therapeutics Inc. ( ($TSE:NURL) ) has provided an announcement. Neural Therapeutics Inc. has reported strong financial results for its portfolio company, CWE European Holdings Inc., which operates as Hanf.com,
NURL FAQ
What was Neural Therapeutics Inc.’s price range in the past 12 months?
What is Neural Therapeutics Inc.’s market cap?
When is Neural Therapeutics Inc.’s upcoming earnings report date?
Is Neural Therapeutics Inc. overvalued?
Does Neural Therapeutics Inc. pay dividends?
What is Neural Therapeutics Inc.’s EPS estimate?
How many shares outstanding does Neural Therapeutics Inc. have?
Which hedge fund is a major shareholder of Neural Therapeutics Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Neural Therapeutics Inc.
Neural Therapeutics is an ethnobotanical drug discovery company, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. The Company's innovative approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy.
- Sector
- General
- Industry
- Biotechnology
- Employees
- 0
- Address
- 130 Adelaide St. West,Suite 3002, Toronto, Ontario, M5H 3P5, CA
Neural Therapeutics Inc. (NURL) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 1 | 15 |
| Technical Analysis | 5 | 1 | 4 |
| Moving Averages | 1 | 0 | 11 |











